NewEdge Advisors LLC Has $1.76 Million Stock Position in Tempus AI, Inc. $TEM

NewEdge Advisors LLC increased its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 2,420.6% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 36,548 shares of the company's stock after purchasing an additional 35,098 shares during the period. NewEdge Advisors LLC's holdings in Tempus AI were worth $1,763,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. KADENSA CAPITAL Ltd acquired a new stake in Tempus AI during the first quarter worth approximately $22,130,000. Advisors Asset Management Inc. grew its stake in Tempus AI by 753.9% during the first quarter. Advisors Asset Management Inc. now owns 17,377 shares of the company's stock worth $838,000 after purchasing an additional 15,342 shares during the period. Royal Bank of Canada grew its stake in Tempus AI by 201.2% during the first quarter. Royal Bank of Canada now owns 25,988 shares of the company's stock worth $1,253,000 after purchasing an additional 17,359 shares during the period. Quarry LP acquired a new stake in Tempus AI during the first quarter worth approximately $44,000. Finally, Titleist Asset Management LLC acquired a new stake in Tempus AI during the first quarter worth approximately $2,361,000. Institutional investors and hedge funds own 24.22% of the company's stock.

Tempus AI Stock Performance

Shares of TEM opened at $86.38 on Friday. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. The company has a market capitalization of $15.01 billion, a price-to-earnings ratio of -72.59 and a beta of 5.08. The stock has a 50 day moving average of $67.61 and a 200 day moving average of $59.61. Tempus AI, Inc. has a 12 month low of $31.36 and a 12 month high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. The company had revenue of $314.64 million during the quarter, compared to the consensus estimate of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.Tempus AI's revenue was up 89.5% on a year-over-year basis. During the same period last year, the business posted ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. As a group, sell-side analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Insider Activity at Tempus AI

In related news, EVP Erik Phelps sold 3,664 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $273,517.60. Following the completion of the sale, the executive vice president directly owned 94,115 shares of the company's stock, valued at approximately $7,025,684.75. This trade represents a 3.75% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO James William Rogers sold 7,528 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $561,965.20. Following the sale, the chief financial officer directly owned 138,473 shares of the company's stock, valued at $10,337,009.45. The trade was a 5.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 903,104 shares of company stock valued at $63,733,330 in the last ninety days. Insiders own 26.27% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on TEM. HC Wainwright increased their price target on Tempus AI from $90.00 to $98.00 and gave the stock a "buy" rating in a report on Friday. Piper Sandler reiterated a "neutral" rating on shares of Tempus AI in a report on Friday, August 8th. Morgan Stanley increased their price target on Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a report on Tuesday, August 12th. BTIG Research increased their price target on Tempus AI from $75.00 to $85.00 and gave the stock a "buy" rating in a report on Wednesday, August 20th. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $70.00 price target on shares of Tempus AI in a report on Friday, August 8th. Seven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $70.17.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.